Rafael Holdings to Participate in the Guggenheim 3rd Annual Healthcare Innovation Conference
Globe Newswire•03/11/2026•11:14 ET
1
Key Highlights
- ➤Rafael Holdings (RFL) will host a fireside chat at Guggenheim’s healthcare conference November 9
- ➤Rafael Holdings submitted an NDA for remibetadex to the FDA in October 2026
- ➤Phase 3 TransportNPC study missed its primary endpoint in the overall population
- ➤Rafael Holdings cites substantial doubt about its ability to continue as a going concern
NEWARK, N.J., Nov. 03, 2026 (GLOBE NEWSWIRE) -- Rafael Holdings, Inc. (NYSE: RFL) today announced that it will participate in a fireside chat at the Guggenheim 3rd Annual Healthcare Innovation Conference in Boston on Monday, November 9, 2026 at 3:55 p.m. ET, and host one-on-one meetings with institutional investors.
A live webcast can be accessed with this link: https://event.summitcast.com/view/oVDtKqmPn2tPc7VV7WsLAC/ACx7UpLgLXHM3BVo56spTQ. A replay will be available approximately two hours after the completion of the event and will be archived for up to 30 days.
Get started
Create a free account to read the full story.